14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.31 $4.00 Friday, 3rd May 2024 CYCC stock ended at $2.00. This is 19.68% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 28.15% from a day low at $1.94 to a day high of $2.48.
90 days $1.31 $4.00
52 weeks $1.31 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Feb 23, 2023 $14.25 $14.85 $14.08 $14.25 3 544
Feb 22, 2023 $15.30 $15.72 $14.25 $14.25 6 471
Feb 21, 2023 $16.05 $16.20 $15.15 $15.30 4 814
Feb 17, 2023 $17.25 $17.40 $16.35 $16.50 2 336
Feb 16, 2023 $15.75 $17.55 $15.75 $17.25 12 199
Feb 15, 2023 $15.75 $16.20 $15.15 $15.75 1 561
Feb 14, 2023 $15.75 $16.35 $15.23 $15.75 1 769
Feb 13, 2023 $15.60 $16.65 $15.45 $15.75 10 218
Feb 10, 2023 $14.95 $15.60 $14.55 $15.45 991
Feb 09, 2023 $16.20 $16.35 $14.47 $15.15 4 628
Feb 08, 2023 $16.35 $16.65 $15.15 $15.75 4 501
Feb 07, 2023 $15.15 $16.50 $15.15 $15.60 1 490
Feb 06, 2023 $15.60 $16.50 $14.72 $15.15 7 089
Feb 03, 2023 $16.05 $17.25 $15.15 $15.90 8 208
Feb 02, 2023 $14.25 $16.50 $14.25 $16.35 11 097
Feb 01, 2023 $13.61 $14.37 $13.61 $14.25 3 008
Jan 31, 2023 $13.95 $14.10 $13.35 $13.56 4 959
Jan 30, 2023 $13.20 $13.79 $13.20 $13.65 3 260
Jan 27, 2023 $14.55 $14.55 $13.07 $13.20 4 704
Jan 26, 2023 $13.50 $14.82 $13.50 $14.25 2 207
Jan 25, 2023 $13.50 $14.10 $12.23 $13.05 4 493
Jan 24, 2023 $14.36 $14.85 $13.34 $13.43 3 707
Jan 23, 2023 $14.55 $15.45 $13.91 $14.06 5 021
Jan 20, 2023 $14.57 $15.00 $14.25 $14.70 3 148
Jan 19, 2023 $14.39 $14.87 $14.10 $14.25 3 896
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT